Reducing Avoidable Protocol Amendments in Clinical Trials

This technical report investigates the patterns of protocol amendments in clinical trials, focusing on the operational challenges that lead to these changes. It utilizes a proprietary dataset from Advarra, encompassing over 30,000 studies, to identify common drivers of amendments across various therapeutic areas (TAs). The report is structured into three parts: the first part examines the average rates of amendments, revealing limited variation across TAs and highlighting the need for better study design to prevent avoidable changes. The second part analyzes cross-TA amendment driver patterns, showing how different TAs exhibit unique drivers that influence protocol changes. The final part delves into specific TAs, such as Autoimmune and Oncology, to illustrate how amendment patterns diverge based on distinct scientific and operational pressures. Overall, the report emphasizes the importance of proactive, data-informed study design to anticipate and mitigate potential protocol amendments, thereby improving trial efficiency and reducing burdens on sites and participants.